Philadelphia Life Sciences Team

Colliers International recently structured a lease for Cellectis, a Paris based clinical-stage biopharmaceutical company, to create an 82,000 square foot commercial-scale manufacturing facility named IMPACT (Innovative Manufacturing Plant for Allogeneic Cellular Therapies) in Raleigh, North Carolina, for clinical and commercial production of Cellectis’ leading allogeneic UCART products.

With products in clinical trials, the Cellectis team was under time pressure to identify and build out a US manufacturing plant that would enable them to meet their manufacturing and marketing timeline. The search was limited to the East Coast to enable easy access to Paris. Key factors informing the search were depth of skilled workforce, cost of living, suitable building configuration and infrastructure...read more

The Colliers Life Sciences Group was tasked with packaging and selling the NEOSE Technologies process facility, a 50,000-square-foot biologics manufacturing facility with two 3,000 Litre Mammalian Cell Manufacturing Sites, back within the industry to a company with a pipeline of products in the clinical stages of development. The facility was already 10 years old at the date of sale.

We identified through substantial research the names of those companies who were in Phases I, II and III with a strategy to develop and manufacture their product internally and not contract with a CMO....read more

Tengion is a development-stage regenerative medicine company that required a first-of-its-kind facility utilizing current good manufacturing practices (cGMP) to manufacture autologous cells for the regeneration of bladder cells. The building required spaces for quality assurance, quality control, tissue culture and an open sterile manufacturing room for an incubator farm to produce the replacement bladders.

Tengion hired the Colliers team to perform a site-selection survey with a comparative analysis between two states, Pennsylvania and North Carolina. The site had to be free of vibrations that might impact the analytical equipment, have the potential to accommodate 2,000 amps of power, offer access to dark fiber and provide sufficient equivalent dwelling units (EDUs) to...read more

The global Life Sciences Practice Group at Colliers spans multiple markets. In Connecticut, LSPG retains sole leasing responsibility for Science Park at Yale, a large research park that is the former manufacturing center of the Winchester Repeating Arms Company.

Colliers has worked with ownership and tenants to keep the complex occupied, productive and vibrant for a decade. To date, more than 150,000 square feet in the complex has been leased at a value of more than $20 million. Long term representation of the property has included transactions for lab and vivarium space with companies in various phases of their development cycle...read more